Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000910
Status:
COMPLETED
Last Update Posted:
2013-10-07
First Post:
1999-11-02
Brief Title:
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Medical Chart Abstraction of HIV-Infected Pregnant Women and Their Infants Receiving Care or Consultation at Study Sites
Status:
COMPLETED
Status Verified Date:
2013-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to collect medical information about HIV-positive pregnant women and their babies who have been or are being seen at study sites This information will be used to help design future research studies for these patients
The population of HIV-positive pregnant women and their babies who are seen at study sites has not been officially examined In order to design future studies to research the best care for these patients this study will examine important characteristics and the general number of women in these trials
The population of HIV-positive pregnant women and their babies who are seen at study sites has not been officially examined In order to design future studies to research the best care for these patients this study will examine important characteristics and the general number of women in these trials
Detailed Description:
The population served at affiliated ACTG sites has not been officially described Anecdotal evidence however has surfaced regarding the characteristics of HIV-infected pregnant women and the current standard of care during pregnancy This chart abstraction study is designed to define more accurately the pertinent characteristics and general numbers of women in these trials
In this medical chart abstraction study pertinent information is collected on all HIV-infected pregnant women and their infants who receive primary or consultative care at PACTG 367 study sites Part A profiles all HIV-infected women who received care or consultation at study sites and who had a pregnancy outcome between January 1 1998 through July 1 1998 AS PER AMENDMENT 041202 Part A is closed to enrollment Part B profiles HIV-infected pregnant women who receive primary or consultative care and a pregnancy outcome following July 1 1998
In this medical chart abstraction study pertinent information is collected on all HIV-infected pregnant women and their infants who receive primary or consultative care at PACTG 367 study sites Part A profiles all HIV-infected women who received care or consultation at study sites and who had a pregnancy outcome between January 1 1998 through July 1 1998 AS PER AMENDMENT 041202 Part A is closed to enrollment Part B profiles HIV-infected pregnant women who receive primary or consultative care and a pregnancy outcome following July 1 1998
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 11330 | REGISTRY | DAIDS-ES | None |
| PACTG 367 | None | None | None |